Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
300.79
+2.50 (0.84%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 168.8 | 759.9 | -1,844 | -637.3 | -3,628 | 4,254 |
Depreciation & Amortization | 168.2 | 165.4 | 151.6 | 145.9 | 137.3 | 137.6 |
Loss (Gain) From Sale of Assets | - | - | - | -2.5 | -1.4 | - |
Asset Writedown & Restructuring Costs | 172.8 | 172.8 | 29.5 | - | - | - |
Loss (Gain) From Sale of Investments | -124.4 | -894.4 | 2,657 | 1,252 | 5,206 | -4,925 |
Stock-Based Compensation | 57.7 | 58 | 62.3 | 61.3 | 60.9 | 51.2 |
Other Operating Activities | 5.6 | -3.3 | 20 | -12 | 22.1 | 8.74 |
Change in Accounts Receivable | 13.2 | 19.6 | 16.2 | 11.4 | -87.4 | -20.4 |
Change in Inventory | 56.9 | 68.9 | 8.5 | -46.3 | -158.8 | 46.1 |
Change in Accounts Payable | -20.3 | -0.1 | -40.9 | -51.8 | -94.2 | 69.9 |
Change in Income Taxes | -14.4 | 1.5 | 24.1 | -21.3 | -1.2 | -28.8 |
Change in Other Net Operating Assets | 19.6 | 12 | -1.9 | -2.2 | -26.8 | -8.6 |
Operating Cash Flow | 510.4 | 532.2 | 455.2 | 374.9 | 194.4 | 669.5 |
Operating Cash Flow Growth | -0.95% | 16.92% | 21.42% | 92.85% | -70.96% | 14.44% |
Capital Expenditures | -153.2 | -157.6 | -165.6 | -156.7 | -112.8 | -133.75 |
Sale of Property, Plant & Equipment | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.05 |
Cash Acquisitions | -218.5 | -218.5 | - | - | -100.7 | -125.52 |
Divestitures | - | - | - | 2.5 | 1.4 | - |
Sale (Purchase) of Intangibles | - | - | -23.4 | - | -1.5 | - |
Investment in Securities | 85.7 | 186.3 | 28.7 | 174.2 | -994.2 | -84.73 |
Investing Cash Flow | -285.8 | -189.7 | -160.2 | 20.2 | -1,208 | -797.38 |
Long-Term Debt Issued | - | - | - | - | 1,186 | - |
Long-Term Debt Repaid | - | -0.5 | -0.4 | -0.5 | -0.5 | -3.02 |
Net Debt Issued (Repaid) | -0.5 | -0.5 | -0.4 | -0.5 | 1,186 | -3.02 |
Issuance of Common Stock | 14.9 | 15.8 | 19.2 | 18.5 | 17.6 | 20.63 |
Repurchase of Common Stock | -244.4 | -298.5 | -207 | -443.6 | -229.7 | -72.48 |
Other Financing Activities | 0.5 | - | -30.6 | - | - | -0.56 |
Financing Cash Flow | -229.5 | -283.2 | -218.8 | -425.6 | 973.6 | -55.43 |
Foreign Exchange Rate Adjustments | -9.2 | -16.9 | 9.2 | 0.4 | 3 | -12.64 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0.04 |
Net Cash Flow | -14.1 | 42.4 | 85.4 | -30.1 | -36.6 | -195.98 |
Free Cash Flow | 357.2 | 374.6 | 289.6 | 218.2 | 81.6 | 535.75 |
Free Cash Flow Growth | 0.48% | 29.35% | 32.72% | 167.40% | -84.77% | 12.45% |
Free Cash Flow Margin | 13.79% | 14.50% | 11.28% | 8.17% | 2.91% | 18.33% |
Free Cash Flow Per Share | 13.21 | 13.73 | 10.26 | 7.47 | 2.74 | 17.74 |
Cash Income Tax Paid | 64.7 | 61.6 | 99.4 | 129.6 | 158.3 | 134.68 |
Levered Free Cash Flow | 229.76 | 256.55 | 193.49 | 124.28 | 2.86 | 485.98 |
Unlevered Free Cash Flow | 260.58 | 287.18 | 224.05 | 155.16 | 26.68 | 486.95 |
Change in Working Capital | 60.3 | 272.4 | -620.8 | -432.8 | -1,610 | 1,143 |